Newton, MA, United States of America

Lisa L Von Moltke

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Alkermes Pharma Ireland Limited. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lisa L Von Moltke. Retrieved from https://idiyas.com/inventor/lisa-l-von-moltke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Lisa L Von Moltke

Introduction

Lisa L Von Moltke is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of pharmacology, particularly in the treatment of schizophrenia. With a total of 2 patents to her name, her work has garnered attention in the medical community.

Latest Patents

One of her latest patents focuses on an innovative dosing strategy for aripiprazole. This invention relates to methods of treating schizophrenia using a combination of aripiprazole, aripiprazole lauroxil, and a nanoparticle dispersion of aripiprazole lauroxil. This approach aims to enhance the efficacy of treatment for patients suffering from this mental health condition.

Career Highlights

Lisa is currently associated with Alkermes Pharma Ireland Limited, where she continues to develop groundbreaking solutions in the pharmaceutical industry. Her expertise and dedication to improving patient outcomes have made her a valuable asset to her team.

Collaborations

Throughout her career, Lisa has collaborated with notable professionals in her field, including Peter J Weiden and Marjie L Hard. These partnerships have contributed to the advancement of her research and innovations.

Conclusion

Lisa L Von Moltke's contributions to the field of pharmacology, particularly in schizophrenia treatment, highlight her innovative spirit and commitment to improving mental health care. Her work continues to inspire future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…